Popular weight-loss drug may leave stomach full despite fasting, study warns
NCT ID NCT07398222
First seen Feb 10, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study looks at whether people taking tirzepatide (a drug for obesity and diabetes) still have food or liquid in their stomach after the recommended fasting times. Using a simple ultrasound, researchers will compare tirzepatide users to non-users. The goal is to understand if these users face a higher risk of stomach contents entering the lungs during anesthesia, a serious complication. About 30 adults will participate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FULL STOMACH STATUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Israelita Albert Einstein
RECRUITINGSão Paulo, São Paulo, 05652900, Brazil
Conditions
Explore the condition pages connected to this study.